Skip to main content

Table 5 Comparison of MAPSE and global strain values in patients treated and not treated by corticosteroids

From: Quantitative assessment of left ventricular longitudinal function and myocardial deformation in Duchenne muscular dystrophy patients

  Group B (LGE + , LV EF ≥ 50%) n = 13 Group C (LGE −, LV EF ≥ 50%) n = 30
  Corticosteroid-treated (n = 6) No corticosteroids (n = 7) p value Corticosteroid-treated (n = 15) No corticosteroids (n = 15) p value
GLS (%) − 19.15 ± 1.86 − 19.14 ± 3.22 1.00 − 20.95 ± 3.63 − 23.32 ± 4.61 0.16
GCS (%) − 26.51 ± 5.38 − 23.36 ± 6.04 0.35 − 25.19 ± 3.53 − 27.74 ± 4.73 0.14
GRS (%) 55.34 ± 10.69 46.26 ± 16.28 0.27 56.70 ± 16.75 63.80 ± 14.53 0.27
MAPSE (mm) 10.83 ± 1.13 10.71 ± 1.93 0.90 11.23 ± 1.66 12.08 ± 1.90 0.22
MAPSE lateral (mm) 11.00 ± 1.90 11.57 ± 2.51 0.66 12.40 ± 1.99 12.92 ± 2.56 0.55
MAPSE septal (mm) 10.67 ± 1.21 9.86 ± 1.86 0.38 10.07 ± 1.53 11.23 ± 1.54 0.06
  1. Variables are expressed as the mean ± standard deviation
  2. LGE +, positive late gadolinium enhancement; LGE–, negative late gadolinium enhancement; LV, left ventricle; EF, ejection fraction; GLS, global longitudinal strain; GCS, global circumferential strain; GRS, global radial strain; MAPSE, mitral annular plane systolic excursion